RIL
DNLI icon

Rothschild Investment LLC’s Denali Therapeutics DNLI Stock Holding History

Rothschild Investment LLC’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.2K Buy
437
+149
+52% +$3.06K ﹤0.01% 1816
2026
Q1 		$5.53K Buy
288
+93
+48% +$1.85K ﹤0.01% 2002
2025
Q4 		$3.22K Sell
195
-30
-13% -$506 ﹤0.01% 2121
2025
Q3 		$3.27K Sell
225
-100
-31% -$1.44K ﹤0.01% 1932
2025
Q2 		$4.55K Buy
325
+260
+400% +$3.66K ﹤0.01% 1559
2025
Q1 		$884 Sell
65
-35
-35% -$671 ﹤0.01% 2408
2024
Q4 		$2.04K Sell
100
-50
-33% -$1.28K ﹤0.01% 1789
2024
Q3 		$4.37K Buy
150
+90
+150% +$2.23K ﹤0.01% 1348
2024
Q2 		$1.39K Buy
60
+50
+500% +$960 ﹤0.01% 1511
2024
Q1 		$205 Buy
+10
New +$188 ﹤0.01% 1731

Other funds holding DNLI

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Rothschild Investment LLC's DNLI Position: Q2 2026 in Review

Rothschild Investment LLC increased its Denali Therapeutics (DNLI) stake by 52% in Q2 2026, buying an estimated $3.06K and bringing the position to 437 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1816.

Rothschild Investment LLC first reported a position in DNLI in Q1 2024 and has held it in 10 quarters since. 273 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • Rothschild Investment LLC held 437 shares of Denali Therapeutics worth $11.2K as of Q2 2026.
  • Rothschild Investment LLC bought 149 Denali Therapeutics shares in Q2 2026, an estimated $3.06K.
  • Denali Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1816 holding.
  • Rothschild Investment LLC first reported a position in Denali Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 273 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.